On January 12, 2010, a devastating earthquake hit Haiti, killing more than 230,000 people and displacing approximately 1.5 million. Children were orphaned; families were left homeless; and homes, schools and hospitals destroyed. Five years later, SOS Children’s Villages, the world’s largest organization providing care for orphaned and abandoned children, remains unwavering in its ongoing, long-term commitment to the people of Haiti.
“Efforts to rebuild the most affected areas move at a slow place, and the need to support vulnerable children and families remains high. Many of the children and families who survived the earthquake lost everything and experienced severe emotional trauma,” said Lynn Croneberger, CEO of SOS Children’s Villages – USA. “In 2010, we made a strong commitment to support these survivors. Thanks to generous donors and the Government of Haiti, we are able to continue to provide support to Haiti’s most vulnerable.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409351-sos-children-village-milestones/
Safe Horizon, the nation’s largest victim services agency, has opened a new Child Advocacy Center (CAC) in the Bronx, with significant support from the de Blasio Administration. This center will be staffed by experts from Safe Horizon, the Administration for Children’s Services, the New York Police Department, the Bronx District Attorney’s Office, the New York City Law Department and Montefiore Medical Center. Together, this team of experts will investigate and respond to the most serious cases of sexual and severe physical child abuse in the Bronx.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7448051-safe-horizon-child-advocacy-center/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Latin America
Dr. Gioconda Gaudiano from Republic of Panama
Moon Children - Providing mobile surgery clinics to Indigenous people
This initiative provides free consultations, medical treatment and sun education via mobile surgery clinics to the 40,000 indigenous people from the Archipelago of San Blas, a region with the highest incidence of albinism in the world. Albinos can face severe skin problems, such as skin cancer, caused by UV light and sun exposure due to the lack of melanin in their skin. The mobile surgery clinics are able to travel to the Archipelago of San Blas, a community that often shuns medical treatment and avoids protective measures against skin cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For North America
Dr. Danielle Marcoux from Canada
Camp Liberté – Summer camp for children with skin disorders
This one-week summer camp run by volunteer dermatologists and nurses enrolled children aged 7 to 12 with moderate-to-severe skin disorders, as well as their families, to bring them together for support, social interaction and to increase their confidence. All the activities aim to increase patients’ confidence and self-esteem, improve social skills, reduce stigma about their condition and improve adherence to treatment.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
XCMG, the world’s fifth largest construction equipment company, unveils the XE15R hydraulic intelligent excavator, its first fully remote-controlled excavator, signaling a new phase in XCMG’s intelligentization of its excavator series.
Without a cab, XE15R is the company’s smallest excavator at 1.35m in height and 1.08m in width. Nicknamed “Little Swan”, the machine is agile and flexible in challenging working conditions.
The newly developed XE15R features a wireless control function with a 100-meter range, and integrates mechanic, electronic and hydraulic control technology with a CAN bus interface design. Unmanned driving reduces labor intensity, particularly useful in severe operating environments, such as toxic conditions or extreme temperatures.
As an intelligent excavator, XE15R also features a self-learning function. It can save operating maneuvers and then replay them automatically on request, a breakthrough that further ensures security, agility and reliability in operation.
“Intelligentization is an inevitable choice as XCMG follows the path of new industrialization, and XE15R shows that we do what we say. Its design embodies our pursuit of efficiency and user friendliness.” said Wang Min, president of XCMG. The launching of XE15R expands XCMG’s product line, and improves its customers’ construction quality, providing them with a more human-friendly working environment and better project solutions.
To view the multimedia release please visit
http://www.multivu.com/players/English/7605551-xcmg-xe15r-remote-controlled-excavator/
Over 6,700 of the most influential people in the duty free & travel retail community converged on Cannes on the French Cote d’Azur last month for the annual TFWA World Exhibition & Conference.
This global trade summit is a not-to-be-missed event in the industry’s calendar and even severe flooding in the city just prior to the event could not deter the 3,000 companies from sending their representatives to the event.
Erik Juul-Mortensen, TFWA President. “The fact that TFWA World Exhibition & Conference opened on schedule just two weeks after the appalling flooding in the city, with virtually all facilities laid on as planned, is thanks to the energy and commitment of our partners in the city.”
However, the fact that the overall attendance was actually two per cent lower than in 2014 is testament to the difficult trading conditions which prevail this year with various geopolitical and economic challenges impacting global travel, tourism and retail.
Fortunately for the 482 exhibiting companies which were showcasing their products on the 21,500m2 trade floor, the number of key buyer companies - duty free & travel retail operators and landlords of airports, airlines, ferry, cruise, border and downtown concerns – was actually four per cent above last year’s figure.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7628051-the-duty-free-travel-retail-global-summit/
One to six in 1,000 children in the United States are born with severe to profound hearing loss.1 For a parent, that diagnosis can be life altering, and they are in need of help, information and support. Today, Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces IWantYouToHear.com as part of its ongoing commitment to parents seeking treatment options for their child’s severe to profound hearing loss.
For many parents with a child who has received a hearing loss diagnosis, the wish for their child is immediate and clear: “I want you to hear.” They want their child to hear the birds and their favorite songs, learn to develop speech and language, and most of all, they want their child to hear them say “I love you.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7658351-cochlear-americas-i-want-you-to-hear/
Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
Millions of families will head to the beach this Memorial Day weekend, many without adequate sun protection. As part of a national effort to reduce the incidence of skin cancer, Neutrogena® is kicking off the 2016 Choose Skin Health® Campaign with a video featuring Brand Ambassador Kristen Bell asking moms everywhere to get real with their kids about the importance of sunscreen—and a pledge to donate $1 for every video share to the non-profit Children’s Melanoma Prevention Foundation.*
Bell’s video acknowledging the challenges moms face tackling serious topics with their children is frank and funny—but skin health is no laughing matter. The fact that only 39% of women and 14% of men use sunscreen regularly is a health issue of national importance when you consider that just one to two severe sunburns can increase lifetime risk of developing melanoma by 40 percent.
The Neutrogena® Choose Skin Health® Campaign was created to change the future of skin health and reduce the risk of skin cancer through education, empowerment, and early detection. This year the brand is developing in-school sun safety programs with the potential to reach 1.6 million students annually with a sun safe behavior curriculum, sponsoring 13,000 free skin cancer screenings annually with charitable partners, and working toward a goal of donating $35 million worth of sunscreen to families in need by the end of 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7847951-neutrogena-choose-skin-health/
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most.
Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play.
To view the multimedia release go to:
http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
